Study on adult patients positive to COVID-19 virus. After signing informed consent and undergoing screening assessments, eligible patients will record few times a day several pre-defined sentences to the Cordio App installed in a smartphone/tablet. The app will upload the vocal data to the sponsor's servers for analysis. The patient will record at hospital admittance (COVID-19 positive) until patient defined as COVID-19 negative and free of relevant clinical symptoms.
Device: Cordio App
Adult patients positive to COVID-19 virus will record several predefined sentences via a smartphone / tablet and will answer questions via the app
Inclusion Criteria:
1. 18+ years old
2. Diagnosed with COVID-19 positive patients according to medical center guidelines, with
symptoms of cough and or dyspnea. Patients that diagnosed with pneumonia, should be
confirmed by X-ray and/or CT.
3. Able to understand and provide written informed consent (manually or electronically or
giving their consent via the telephone to the study investigator in case of isolated
patients).
Exclusion Criteria:
1. Subjects, in the Investigator's opinion, unable to comply with the daily use of the
application including mental disorders (e.g., depression, dementia).
2. Patients with severe alcohol or drug use.
3. Women who are pregnant or lactating.
4. Participating in another investigation therapy that may interfere with study results
(according to investigator discretion)
Rambam Medical Center
Haifa, Israel
Investigator: Maria Goldshmidt, Msc
M_GOLDSHMIDT@rambam.health.gov.il
Investigator: Gidon Berger, Dr.
Ronit Haviv, PhD
+97235467163
ronit@cordio-med.com
Zaher Azzam, Prof, Principal Investigator
Rambam Health Care Campus